戻る
Simcere Pharmaceutical Group Limited (02096.HK)価格
02096.HK 株価推移チャート
SIMCERE PHARMA (02096.HK)
Simcere Pharmaceutical Group Limited
HK$11.64
0.17%
$0.02
休場: Jan 16, 16:00:00 HKT
データなしEarnings FAQ
02096.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Simcere Pharmaceutical Group Limited 02096.HKの前四半期の収益はどうでしたか？
Simcere Pharmaceutical Group Limitedの収益見積もりはいくらですか？
Simcere Pharmaceutical Group Limitedの収益品質スコアはどれくらいですか？
Simcere Pharmaceutical Group Limitedはいつ収益を報告しますか？
Simcere Pharmaceutical Group Limitedの予想収益はいくらですか？
Simcere Pharmaceutical Group Limitedは収益予想を上回りましたか？
主要データ
前終値
$11.62
始値
$11.62
当日レンジ
$11.44 - $11.78
52週レンジ
$6.2 - $15.08
取引高
11.0M
平均取引高
8.2M
1株当たり利益(TTM)
0.40
配当利回り
--
時価総額
$30.2B
SIMCERE PHARMAとは何ですか？
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.